DEC 11, 2019 2:20 PM PST

Drug To Treat Ulcerative Colitis

WRITTEN BY: Nouran Amin

Biomedical researchers at the University of California—Riverside, found that the therapeutic drug ‘tofacitinib’ used in treating autoimmunity symptoms of rheumatoid arthritis can also treat gut permeability defects in patients diagnosed with ulcerative colitis. "Our work increases our understanding of how this drug is useful for treating ulcerative colitis," said Declan McCole, a professor of biomedical sciences in the UCR School of Medicine, and the lead author of the study that appears in the journal Inflammatory Bowel Diseases. "We now better understand where in the gut the drug is working, and how."

Ulcerative colitis is a chronic inflammatory bowel disease affecting 1 million Americans. The condition targets the large intestine in the digestive system that results in the lining of the colon becoming inflamed and leaky. But, tofacitinib—often marketed as Xeljianz—can repair the cells lining the gut.

"We found tofacitinib fixes the leakiness in the intestinal barrier," McCole said. "Specifically, it fixes intestinal epithelial permeability defects caused by 'interferon-gamma,' an inflammatory cytokine involved in autoimmune diseases such as ulcerative colitis and rheumatoid arthritis."

Learn more about ulcerative colitis:

Intestinal permeability, or leakiness, is a characteristic of ulcerative colitis and results in inflammation. Researchers believe that tofacitinib targets the inflammation-induced permeability in the lining and prevents fluid loss.

"By targeting specific molecules, the drug inhibits a pathway that is activated by inflammation," said Anica Sayoc-Becerra, a graduate student in the Biomedical Sciences Graduate Program, a member of McCole's lab, and the first author of the research paper. "Our study shows tofacitinib is not just acting on immune cells, as was first thought, but can have a direct effect on the epithelial cells that are the key factor in maintaining gut barrier function."

Source: University of California

About the Author
BS/MS
Nouran is a scientist, educator, and life-long learner with a passion for making science more communicable. When not busy in the lab isolating blood macrophages, she enjoys writing on various STEM topics.
You May Also Like
JUN 27, 2022
Plants & Animals
Developing a New Approach to Rabies Vaccination
JUN 27, 2022
Developing a New Approach to Rabies Vaccination
Rabies is a viral disease that can spread through the saliva. Several kinds of animals can get rabies, including humans ...
JUN 26, 2022
Drug Discovery & Development
Acupuncture Alleviates Chronic Tension Headaches in Randomized Controlled Trial
JUN 26, 2022
Acupuncture Alleviates Chronic Tension Headaches in Randomized Controlled Trial
Results from a randomized controlled trial suggest that acupuncture may relieve symptoms of chronic tension-type headach ...
AUG 02, 2022
Neuroscience
Brain Derived Exosomes; a non-invasive look inside the brain
AUG 02, 2022
Brain Derived Exosomes; a non-invasive look inside the brain
Exosomes are small extracellular vesicles about the size of influenza and corona viruses and have been making news for s ...
JUL 15, 2022
Immunology
Pox Virus Proteins Can Launch Early Attack on Immune Defense
JUL 15, 2022
Pox Virus Proteins Can Launch Early Attack on Immune Defense
After a virus gets inside of a cell, it typically takes over the cell to produce more viral particles. But pox viruses g ...
AUG 11, 2022
Cannabis Sciences
High Doses of CBD Safe for Driving
AUG 11, 2022
High Doses of CBD Safe for Driving
The University of Sydney research team studied the effects of cannabidiol (CBD) on driving, and they found that the high ...
AUG 09, 2022
Immunology
New Small Molecule May Improve Immunotherapy for a Variety of Cancers
AUG 09, 2022
New Small Molecule May Improve Immunotherapy for a Variety of Cancers
Scientists have been trying to stimulate the immune system to fight cancer for decades, and recent years have brought ma ...
Loading Comments...